Dengue virus (DV) enhancing antibody activity in preillness plasma does not predict subsequent disease severity or viremia in secondary DV infection

Journal of Infectious Diseases

Volumn 192, Issue 3, 2005, Pages 510-519

  Laoprasopwattana, Kamolwish ^a,f   Libraty, Daniel H ^a   Endy, Timothy P ^b   Nisalak, Ananda ^e   Chunsuttiwat, Supamit ^d   Vaughn, David W ^c   Reed, George ^a   Ennis, Francis A ^a   Rothman, Alan L ^a   Green, Sharone ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^c U S ARMY MEDICAL RESEARCH AND MATERIEL COMMAND   (United States)

^d MINISTRY OF PUBLIC HEALTH   (Thailand)

^e ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^f Songklanagarind Hospital   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANTIBODY RESPONSE; ANTIGEN ANTIBODY REACTION; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DENGUE; DENGUE VIRUS; DISEASE SEVERITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; THAILAND; VIREMIA; VIRUS ISOLATION; VIRUS PATHOGENESIS; VIRUS PLAQUE; VIRUS TITRATION;

ANTIBODIES, VIRAL; CHILD; DENGUE; DENGUE VIRUS; HUMANS; PLAQUE ASSAY; RECURRENCE; THAILAND; VIREMIA;

EID: 22544457161     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/431520     Document Type: Article

References (39)

1. Henchal EA, Putnak JR. The dengue viruses. Clin Microbiol Rev 1990; 3: 376-96.
2. Pinheiro FP, Corber SJ. Global situation of dengue and dengue haemorrhagic fever, and its emergence in the Americas. World Health Stat Q 1997;50:161-9.
3. Nimmannitya S. Clinical spectrum and management of dengue haemorrhagic fever. Southeast Asian J Trop Med Public Health 1987; 18: 392-7.
4. Sabin AB. Research on dengue during World War II. Am J Trop Med Hyg 1952; 1:30-50.
5. Halstead SB. Pathogenesis of dengue: challenges to molecular biology. Science 1988; 239:476-81.
6. Vaughn DW, Green S, Kalayanarooj S, et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 2000; 181:2-9.
7. Burke DS, Nisalak A, Johnson DE, Scott RM. A prospective study of dengue infections in Bangkok. Am J Trop Med Hyg 1988; 38:172-80.
8. Sangkawibha N, Rojanasuphot S, Ahandrik S, et al. Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. Am J Epidemiol 1984; 120:653-69.
9. Halstead SB. In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. J Infect Dis 1979; 140:527-33.
10. Kliks SC, Nimmanitya S, Nisalak A, Burke DS. Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am J Trop Med Hyg 1988; 38:411-9.
11. Kliks SC, Nisalak A, Brandt WE, Wahl L, Burke DS. Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am J Trop Med Hyg 1989; 40:444-51.
12. Libraty DH, Endy TP, Houng HS, et al. Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. J Infect Dis 2002; 185:1213-21.
13. Endy TP, Nisalak A, Chunsuttitwat S, et al. Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand. J Infect Dis 2004; 189:990-1000.
14. Endy TP, Chunsuttiwat S, Nisalak A, et al. Epidemiology of inapparent and symptomatic acute dengue virus infection: a prospective study of primary school children in Kamphaeng Phet, Thailand. Am J Epidemiol 2002; 156:40-51.
15. World Health Organization (WHO). Dengue hemorrhagic fever: diagnosis, treatment, and control. 2nd ed. Geneva: WHO, 1997:1-58. Available at: http://www.who.int/emc/diseases/ebola/Denguepublication. Accessed 24 June 2005.
16. Endy TP, Nisalak A, Chunsuttiwat S, et al. Spatial and temporal circulation of dengue virus serotypes: a prospective study of primary school children in Kamphaeng Phet, Thailand. Am J Epidemiol 2002; 156:52-9.
17. Houng HS, Chung-Ming Chen R, Vaughn DW, Kanesa-Thasan N. Development of a fluorogenic RT-PCR system for quantitative identification of dengue virus serotypes 1-4 using conserved and serotype-specific 3′ noncoding sequences. J Virol Methods 2001; 95:19-32.
18. Lanciotti RS, Calisher CH, Gubler DJ, Chang GJ, Vorndam AV. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol 1992; 30:545-51.
19. Vaughn DW, Green S, Kalayanarooj S, et al. Dengue in the early febrile phase: viremia and antibody responses. J Infect Dis 1997; 176:322-30.
20. Russell PK, Nisalak A, Sukhavachana P, Vivona S. A plaque reduction test for dengue virus neutralizing antibodies. J Immunol 1967; 99:285-90.
21. Innis BL, Nisalak A, Nimmannitya S, et al. An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate. Am J Trop Med Hyg 1989; 40:418-27.
22. Watanaveeradej V, Endy TP, Samakoses R, et al. Transplacentally transferred maternal-infant antibodies to dengue virus. Am J Trop Med Hyg 2003; 69:123-8.
23. Clarke DH, Casals J. Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses. Am J Trop Med Hyg 1958; 7:561-73.
24. Gentry MK, Henchal EA, McCown JM, Brandt WE, Dalrymple JM. Identification of distinct antigenic determinants on dengue-2 virus using monoclonal antibodies. Am J Trop Med Hyg 1982; 31:548-55.
25. Kontny U, Kurane I, Ennis FA. Gamma interferon augments Fc gamma receptor-mediated dengue virus infection of human monocytic cells. J Virol 1988; 62:3928-33.
26. Guzman MG, Kouri G, Valdes L, Bravo J, Vazquez S, Halstead SB. Enhanced severity of secondary dengue-2 infections: death rates in 1981 and 1997 Cuban outbreaks. Rev Panam Salud Publica 2002; 11:223-7.
27. Diamond MS, Edgil D, Roberts TG, Lu B, Harris E. Infection of human cells by dengue virus is modulated by different cell types and viral strains. J Virol 2000; 74:7814-23.
28. Anonymous. Ecology of arboviruses in Thailand. Annual progress report Southeast Asia Treaty Organization (SEATO). Bangkok, Thailand: US Army-SEATO Medical Research Unit, 1968:43-71.
29. Anonymous. Tick-borne viruses in Thailand. Annual progress report Southeast Asia Treaty Organization (SEATO). Bangkok, Thailand: US Army-SEATO Medical Research Unit, 1975:57-68.
30. Halstead SB, Porterfield JS, O'Rourke EJ. Enhancement of dengue virus infection in monocytes by flavivirus antisera. Am J Trop Med Hyg 1980; 29:638-42.
31. Morens DM, Halstead SB. Measurement of antibody-dependent infection enhancement of four dengue virus serotypes by monoclonal and polyclonal antibodies. J Gen Virol 1990; 71:2909-14.
32. Wu SJ, Grouard-Vogel G, Sun W, et al. Human skin Langerhans cells are targets of dengue virus infection. Nat Med 2000; 6:816-20.
33. Libraty DH, Pichyangkul S, Ajariyakhajorn C, Endy TP, Ennis FA. Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis. J Virol 2001; 75:3501-8.
34. Harris E, Videa E, Perez L, et al. Clinical, epidemiologic, and virologic features of dengue in the 1998 epidemic in Nicaragua. Am J Trop Med Hyg 2000; 63:5-11.
35. Barnes WJ, Rosen L. Fatal hemorrhagic disease and shock associated with primary dengue infection on a Pacific island. Am J Trop Med Hyg 1974; 23:495-506.
36. Scott RM, Nimmannitya S, Bancroft WH, Mansuwan P. Shock syndrome in primary dengue infections. Am J Trop Med Hyg 1976; 25: 866-74.
37. Littaua R, Kurane I, Ennis FA. Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection. J Immunol 1990; 144:3183-6.
38. Gajanana A, Thenmozhi V, Samuel PP, Reuben R. A community-based study of subclinical flavivirus infections in children in an area of Tamil Nadu, India, where Japanese encephalitis is endemic. Bull World Health Organ 1995; 73:237-44.
39. Putvatana R, Yoksan S, Chayayodhin T, Bhamarapravati N, Halstead SB. Absence of dengue 2 infection enhancement in human sera containing Japanese encephalitis antibodies. Am J Trop Med Hyg 1984; 33:288-94.